Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2024-11-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$88.8m
reported value
-14.3% vs Q2 2024
13positions
89.3%in top 10
0 new
5 added
5 reduced
0 sold out
vs Q2 2024
Options: 0 call positions (— notional), 1 put positions ($43.0m notional) – listed below, not included above.
Holdings, Q3 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS IN ARWR | $15.4m17.35% | Reduced -112.7k |
| BLUEPRINT MEDICINES CORP BPMC | $11.5m12.97% | Added +10.0k |
| KYMERA THERAPEUTICS INC KYMR | $9.9m11.12% | Reduced -120.0k |
| REGENXBIO INC RGNX | $9.8m10.99% | Added +24.5k |
| ARVINAS INC ARVN | $9.6m10.78% | Reduced -40.0k |
| MERUS N V MRUS | $5.9m6.63% | Reduced -30.3k |
| SILENCE THERAPEUTICS PLC SLN | $5.8m6.49% | Reduced -183.0k |
| BICYCLE THERAPEUTICS PLC BCYC | $4.1m4.63% | Added +25.2k |
| IMMATICS N.V IMTX | $3.8m4.28% | Added +133.5k |
| ADICET BIO INC COM | $3.6m4.10% | Unchanged |
| PRECISION BIOSCIENCES INC DTIL | $3.4m3.85% | Unchanged |
| REPARE THERAPEUTICS INC RPTX | $3.4m3.83% | Added +32.4k |
| SUTRO BIOPHARMA INC COM | $2.6m2.97% | Unchanged |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $43.0m75.0k shares | New |